Stephan, Clifford individual record
Certification Officer and Associate Professor
Positions:
overview

The Stephan Lab is focused on drug discovery research. Dr. Stephan directs both the Combinatorial Drug Discovery Program (CDDP) core and the Microphysiological Lead Optimization and Toxicity Screening (MLOTS) facilities. The CDDP is a high throughput screening and automated microscopy core focused on discovering new therapeutics from library screening and drug repurposing alone or in multi-drug combinations. MLOTS is a low to medium throughput core focused on lead optimization for new chemical entities with the capability of testing compounds in complex in vitro models (e.g., spheroids, organoids) and de-risking drug leads by evaluating their potential cardiovascular or CNS toxicities via micro electrode array or hepatotoxcity in a microfluidic liver model.

selected publications
Academic Articles19
  • Henderson, Y. C., Mohamed, A., Maniakas, A., Chen, Y., Powell, R. T., Peng, S., ... Lai, S. Y. (2021). A High-Throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.. J Clin Endocrinol Metab. 106(10), 2962-2978.
    doi badge pubmed badge
  • Stossi, F., Dandekar, R. D., Mancini, M. G., Gu, G., Fuqua, S., Nardone, A., ... Mancini, M. A (2020). Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity.. Nucleic Acids Res. 48(4), 1800-1810.
    doi badge pubmed badge
  • Bakthavatsalam, D., Craft, J. W., Kazansky, A., Nguyen, N., Bae, G., Caivano, A. R., ... Woodside, D. G (2020). Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk.. Front Immunol. 11, 575085.
    doi badge pubmed badge
  • Kalu, N. N., Mazumdar, T., Peng, S., Tong, P., Shen, L. i., Wang, J., ... Johnson, F. M (2018). Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants.. Cancer Lett. 431, 64-72.
    doi badge pubmed badge
  • Dong, J., Park, S. Y., Nguyen, N., Ezhilarasan, R., Martinez-Ledesma, E., Wu, S., ... de Groot, J. F (2018). The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.. Oncotarget. 9(12), 10497-10509.
    doi badge pubmed badge
Conference Papers5
  • Bernard, V., Lucas, F., Huang, J., Powell, R. T., Guerrero, P. A., Semaan, A., ... Maitra, A. (2019). Abstract 1402: Single cell transcriptomic profiling ofex vivotumoroid models reveal therapeutic vulnerabilities of pancreatic ductal adenocarcinoma. Clinical Research (Excluding Clinical Trials), Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. 79(13), 1402-1402.
    doi badge
  • Mazumdar, T., Kalu, N. N., Peng, S., Tong, P., Shen, L. i., Wang, J., ... Johnson, F. M. (2018). Abstract 4646: Pharmacogenomic screen identifies KMT2D mutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma. Cancer Research. 78(13_Supplement), 4646-4646.
    doi badge
  • Li, F., Wang, L., Kong, R., Sheng, J., Cao, H., Mancuso, J., ... Wong, S. (2016). DrugMoaMiner: A computational tool for mechanism of action discovery and personalized drug sensitivity prediction. 2016 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI), 2016 IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI). 368-371.
    doi badge
  • Oba, J., Wang, W., Eterovic, A. K., Stephan, C. C., Roszik, J., Kale, C. R., ... Woodman, S. E (2015). A global genomic and small molecule inhibitor interrogation of KIT mutant melanoma to reveal underlying biology and novel molecular targets. JOURNAL OF CLINICAL ONCOLOGY. 33(15),
  • BJERCKE, R. J., STEPHAN, C. C., ERICHSEN, D. A., MARTINEZ, R. E., SHERWOOD, S., OWENS, R., & BROCK, T. A (1995). CHRONIC THERAPY WITH BFGF ANTIBODY REDUCES BALLOON INJURY-INDUCED INTIMAL THICKENING IN RAT CAROTID-ARTERY. FASEB JOURNAL. 9(3), A343-A343.
Email
cstephan@tamu.edu
First Name
Clifford
Last Name
Stephan
mailing address
Texas A&M Health Science Center; Ibt Center For Translational Cancer Research; 2121 W. Holcombe Blvd
Houston, TX 77030-3303
USA